Overview

Donepezil in Preventing Delirium in Hospitalized Elderly

Status:
Completed
Trial end date:
2007-04-01
Target enrollment:
Participant gender:
Summary
The purpose of this study is to explore the efficacy of a perioperative daily dose of Donepezil (a cholinergic enhancer) in reducing the incidence and severity of delirium.
Phase:
Phase 4
Details
Lead Sponsor:
Indiana University Health
Treatments:
Donepezil